NASDAQ · Analyst Forecast

Rallybio Corporation (RLYB) Stock Forecast & Price Target

$15.29 NASDAQ: RLYB Market Cap $82.32M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Rallybio Corporation (RLYB), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Rallybio Corporation, analysts forecast revenue rising from $673,750 in 2024 to $89.00M in 2029; the average estimate for 2029 earnings per share is $3.92; 3 analysts contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2024$673,750$673,750$673,7503
2025$572,729$700,000$763,6393
2026$80,000$80,000$80,0001
2027$87.90M$87.90M$87.90M1
2028$87.50M$87.50M$87.50M1
2029$89.00M$89.00M$89.00M1

Earnings per share forecast

YearLowAverageHighAnalysts
2024−$11.53−$11.36−$11.193
2025−$1.80−$1.80−$1.803
2026−$5.52−$5.52−$5.521
2027−$11.52−$11.52−$11.521
2028−$3.12−$3.12−$3.121
2029$3.92$3.92$3.921

Rallybio Corporation (RLYB) forecast — frequently asked questions

What are analysts forecasting for Rallybio Corporation's earnings?

The average analyst estimate for Rallybio Corporation (RLYB) earnings per share in 2029 is 3.92, with individual estimates between 3.92 and 3.92.

How much revenue is Rallybio Corporation expected to make?

Analysts forecast Rallybio Corporation (RLYB) revenue of $89.00M in 2029, based on 1 published estimates.

How many analysts cover RLYB?

3 analysts contribute estimates for Rallybio Corporation (RLYB). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.